A real complaint, an unseen connection
Irritable bowel syndrome (IBS, often called the restless gut) involves recurrent, non-constant abdominal pain or discomfort together with a change in bowel habits. It is described not as a diagnosis of exclusion but as a disorder of gut-brain interaction. Using the Rome IV criteria, its worldwide frequency has been reported as 4.1%; it is about 1.7 times more common in women than in men.
When there are no alarm features, a positive diagnosis can be made from the symptoms with limited testing. Guidelines do not recommend routine colonoscopy for people without alarm features. The physician decides the diagnosis and the extent of testing, drawing on the Rome criteria. Rome IV asks for symptoms on at least one day a week over the last three months, with onset at least six months before diagnosis. Rome V words the frequency as an average of at least three days a month over the last three months and expects the pain not to be related only to menstruation. Subtypes are divided by stool form into diarrhea-predominant, constipation-predominant, mixed and unclassified.
The three phases of a low-FODMAP trial
- 1. Restriction (2–6 weeks)High-FODMAP foods are reduced and the response is assessed.
- 2. Reintroduction (6–8 weeks)Groups are added back one at a time and triggers are identified.
- 3. Personalization (long term)Only problem foods are limited; variety is kept.
A two-way road between brain and gut
The brain and the gut communicate constantly through the autonomic nervous system (including the vagus nerve), the stress-hormone axis, the immune system and substances made by microbes. On the brain side, stress, anxiety, poor sleep and focusing on symptoms can heighten the perception of pain. On the gut side, heightened sensitivity, altered movement, differences in the microbiota (the community of gut microbes) and changes in permeability are described.
That is why a lifestyle approach touches both ends of the road: food and movement target the gut, while sleep and stress management target the brain. This framework also answers the worry 'if nothing was found, is it all in my head?': the symptoms are real, and how they can arise can be described.
In IBS the symptoms are real; a steady routine that looks after gut and brain together is the first step of treatment.
Routine first: the first step
The first step is routine, not restriction. Three meals a day are eaten at regular times without rushing, and skipping meals and heavy late-night eating are avoided. Soluble fiber is increased gradually, whereas bran-type insoluble fiber may worsen symptoms. Caffeine is limited to 2–3 cups a day; alcohol, carbonated and energy drinks, and very fatty or spicy meals are reduced, and plenty of water is consumed. Sugar-free gum and sweets containing sorbitol and mannitol can also worsen diarrhea and bloating.
For the brain end of the axis, movement, sleep and stress management come to the fore. Moderate-to-vigorous activity on 3–5 days a week for 20–60 minutes significantly reduced symptom severity in one randomized trial, and yoga also appears helpful. A fixed bedtime, limiting screens and caffeine before bed, diaphragmatic breathing (belly breathing), regular breaks and social contact are among the suggestions.
Low FODMAP: a trial, not a lifelong diet
FODMAP is the short name for certain groups of foods made up of fermentable oligosaccharides, disaccharides, monosaccharides and polyols. The low-FODMAP diet is a three-phase test done with a dietitian, used as a second step for selected people who did not respond to the first step. First, high-FODMAP foods are reduced for 2–6 weeks and the response is watched. Then, over 6–8 weeks, groups are added back one at a time to find the triggers. In the last phase only problem foods are limited and variety is kept.
In Turkish cooking, high-FODMAP examples include onion, garlic, chickpeas, dried beans, apples, pears, watermelon, dried apricots, honey, milk and wheat bread. Low-FODMAP options include rice, potatoes, oats, lactose-free milk, eggs, zucchini, carrots, tomatoes, oranges and strawberries. If you have a fear of eating or are losing weight, it is important to tell your physician before starting any restrictive diet.
Alarm features and practices with weak evidence
If certain features are present, another disease is considered first: rectal bleeding, unintentional weight loss, iron deficiency anemia, diarrhea that wakes you from sleep, new symptoms after age 50, a family history of colorectal cancer, inflammatory bowel disease or celiac disease, and an abdominal mass. If any of these is present, see a physician without waiting.
Guidelines do not recommend IgG food intolerance testing, because it shows exposure rather than intolerance. A gluten-free diet is also not recommended without celiac disease. There is no evidence for colon cleansing or detox. Probiotics can be tried as a single product for 12 weeks and stopped if there is no benefit. If there is no response, a physician may consider options such as gut-directed cognitive behavioral therapy and hypnotherapy; these are used alongside medical care and medicines, not in place of them.
The overall framework is stepwise. The first step is for everyone: explaining the diagnosis and the axis, plus lifestyle measures. The second step, for selected people, includes a low-FODMAP trial with a dietitian and symptom-targeted medicines. In resistant cases, gut-brain therapies come into play. Which medicine is suitable is for the physician to decide.
Further reading
- Vasant DH et al. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut 2021;70:1214–1240.
- Lacy BE et al. ACG clinical guideline: management of irritable bowel syndrome. Am J Gastroenterol 2021;116:17–44.
- Ford AC, Sperber AD, Corsetti M, Camilleri M. Irritable bowel syndrome. Lancet 2020;396:1675–1688.
- Johannesson E et al. Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol 2011;106:915–922.
- Black CJ et al. Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut 2020;69:1441–1451.
Sources
- British Society of Gastroenterology guidelines on the management of irritable bowel syndrome Vasant DH ve ark., Gut 2021;70(7):1214–1240
- ACG Clinical Guideline: Management of Irritable Bowel Syndrome Lacy BE ve ark., Am J Gastroenterol 2021;116(1):17–44
- Bowel Disorders (Rome V) Corsetti M ve ark., Gastroenterology 2026;170(6):1261–1282
- Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study Sperber AD ve ark., Gastroenterology 2021;160(1):99–114
- Irritable bowel syndrome Ford AC, Sperber AD, Corsetti M, Camilleri M, Lancet 2020;396(10263):1675–1688
Last updated: October 2026